BIOPLASTY SETTLES PATENT INFRINGEMENT SUIT
BIOPLASTY SETTLES PATENT INFRINGEMENT SUIT ST. PAUL, Minn., May 1 /PRNewswire/ -- Bioplasty, Inc.
(NASDAQ-NMS: BIOP) announced today that it has settled the lawsuit brought by McGhan Medical Corporation alleging Bioplasty's silicone gel- filled mammary implant shells infringed two of McGhan's U.S. patents relating to breast implants. Bioplasty has paid McGhan a $275,000 lump sum payment for all prior sales and for a non-exclusive license for future sales, if any, of silicone gel-filled breast implants. Bioplasty has previously announced that it has withdrawn from the domestic and foreign silicone gel-filled breast implant markets.
Bioplasty, Inc. has more the 20 years experience in the development, manufacturing and marketing of plastic surgery products worldwide. Bioplasty's stock is currently traded on NASDAQ National Market System under the symbol "BIOP." -0- 5/1/92 /CONTACT: Timothy P. Lawin or Donald A. Major, 612-636-4112, both of Bioplasty/ (BIOP) CO: Bioplasty, Inc. ST: Minnesota IN: MTC SU:
AL -- MN016 -- 5690 05/01/92 18:00 EDT
|Printer friendly Cite/link Email Feedback|
|Date:||May 1, 1992|
|Previous Article:||WASHINGTON STATE BOARD CANCELS HEARINGS ON SUSPENDED PHARMACIES' LICENSES|
|Next Article:||BIOMIRA ANNOUNCES 1992 FIRST QUARTER FINANCIAL RESULTS|